Cytodyn, Inc.

This study tested whether a weekly injection called PRO 140 could maintain control of HIV over the long term, replacing the standard daily combination of pills. It involved 20 adults whose HIV was already well-controlled on standard therapy. Participants switched to receiving onl…

This study tested whether people with well-controlled HIV could continue using weekly PRO140 injections alone to maintain viral suppression long-term. The research followed 56 participants who had already completed 48 weeks of treatment in a previous study. The main goals were to…

This study aimed to provide continued access to a weekly injection called PRO140 for HIV patients who had successfully completed an earlier trial and were benefiting from the treatment. The research followed 43 treatment-experienced patients to monitor how well the injection kept…

This study tested whether adding an experimental drug called leronlimab to standard chemotherapy (carboplatin) could help control advanced triple-negative breast cancer that had a specific marker (CCR5+). The first part aimed to find a safe dose, and the second part planned to se…